Centiva Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-86,200
Closed -$14M 2037
2024
Q3
$14M Buy
86,200
+71,200
+475% +$11.3M 0.28% 56
2024
Q2
$2.19M Buy
15,000
+14,000
+1,400% +$2.08M 0.04% 372
2024
Q1
$158K Sell
1,000
-21,000
-95% -$3.34M ﹤0.01% 1532
2023
Q4
$3.45M Sell
22,000
-3,500
-14% -$537K 0.08% 230
2023
Q3
$3.97M Sell
25,500
-5,500
-18% -$908K 0.09% 214
2023
Q2
$5.13M Buy
31,000
+16,000
+107% +$2.58M 0.11% 168
2023
Q1
$2.33M Buy
15,000
+5,000
+50% +$807K 0.06% 356
2022
Q4
$1.77M Hold
10,000
0.05% 394
2022
Q3
$1.63M Buy
10,000
+5,000
+100% +$846K 0.03% 423
2022
Q2
$888K Sell
5,000
-5,000
-50% -$891K 0.02% 674
2022
Q1
$1.77M Buy
+10,000
New +$1.7M 0.03% 480
2020
Q3
Sell
-65,400
Closed -$9.2M 786
2020
Q2
$9.2M Sell
65,400
-14,100
-18% -$2.05M 0.55% 27
2020
Q1
$10.4M Sell
79,500
-5,700
-7% -$809K 0.47% 24
2019
Q4
$12.4M Buy
+85,200
New +$11.6M 0.61% 32
2018
Q3
Sell
-80,000
Closed -$9.71M 197
2018
Q2
$9.71M Buy
+80,000
New +$9.98M 2.06% 8

Other funds holding JNJ

Centiva Capital's JNJ Position: Q3 2025 in Review

Centiva Capital sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 4,023 shares — an estimated $615K sold.

Centiva Capital first reported a position in JNJ in Q2 2018 and held it in 23 quarters. The position peaked at $11.5M in Q2 2020. 4,188 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Centiva Capital reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 4,023 Johnson & Johnson shares in Q3 2025, an estimated $615K.
  • Centiva Capital first reported a position in Johnson & Johnson in Q2 2018 and held it in 23 quarters.
  • Centiva Capital's Johnson & Johnson position peaked at $11.5M in Q2 2020.
  • 4,188 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.